Home > Journals > Panminerva Medica > Past Issues > Panminerva Medica 2002 September;44(3) > Panminerva Medica 2002 September;44(3):221-5

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

PANMINERVA MEDICA

A Journal on Internal Medicine


Indexed/Abstracted in: BIOSIS Previews, Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,6


eTOC

 

REVIEW ARTICLES  


Panminerva Medica 2002 September;44(3):221-5

language: English

New antiepileptic drugs in childhood

Verrotti A., Trotta D., Morgese G. *, Chiarelli F.

Department of Paediatrics University of Chieti, Chieti, Italy
*Department of Paediatrics University of Siena, Siena, Italy


PDF  


In ­recent ­years, ­many new anti­epi­leptic ­drugs ­have ­been avail­able for the treat­ment of epi­lepsy in pedi­atric age. In ­this ­review, we ­describe ­these new anti­epi­leptic ­drugs (vigab­a­trin, lamot­ri­gine, fel­ba­mate, gab­a­pentin, tia­ga­bine, topir­a­mate) ­which can be ­used ­together ­with “old” anti­epi­leptic ­drugs (e.g. phe­no­bar­bital, val­proate, etc.). We ­report ­their mech­a­nisms of ­action, effec­tive­ness, ­dosage and ­side ­effects; more­over, ­some prac­tical ­advice for ­their use in pedi­atric ­patients is ­given.

top of page

Publication History

Cite this article as

Corresponding author e-mail